|
Results From The VITAL Cohort Study - News |
Not Signed In - Sign In / Register|
|
Cimetidine Use And The Risk For Prostate Cancer: Results From The VITAL Cohort StudyTue, 03 Oct 2006 07:00 AM EST
... Previously, it was suggested that men filling greater than 20 cimetidine prescriptions were at increased risk of developing prostate cancer (CaP). Cimetidine, but not other H2 blockers, can inhibit dihydrotestosterone from binding to androgen receptors and increase levels of estradiol. This could decrease the risk of CaP. [click link for full article] ... Related Topics |
Every day, thousands of users find businesses like yours in the GoldBamboo directory.
For only $50 a year, a savings of 50% off our standard rate:
The process will take only a few minutes and consists of 3 easy steps:
|
GoldBambooTM Your Integrative Health and Wellness Resource September 6, 2008
|
Page Updated: June 12, 2007
|
Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.
 |
 |
|
email this page
print this page
bookmark this page
feedback on this page
